Tehran University of Medical Sciences

Science Communicator Platform

Faculty Members have conducted research related to the Outcomes of Immunotherapy in Thymoma: A Systematic Review and Meta-Analysis.
Bahram Chahardouli
Bahram Chahardouli

Associate Professor of Laboratory Hematology and Blood Banking

Cell Therapy and Hematopoietic Stem Cell Transplantation Research Center

Tehran University of Medical Sciences

Related Documents
1. A Single Center Study of Prescribing and Treatment Outcomes of Patients With Chronic Myeloid Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2020)
All Documents
1. Wt1 As a Biomarker in Myelodysplastic Neoplasms: Clinical Correlations and Preliminary Data From an Iranian Cohort, International Journal of Hematology-Oncology and Stem Cell Research (2026)
2. Bioinformatics-Guided Construction of a Tumor Microenvironment-Derived Prognostic Model in Acute Myeloid Leukemia, PLOS ONE (2025)
3. Cell Therapy With Placenta-Derived Mesenchymal Stem Cells for Secondary Progressive Multiple Sclerosis Patients in a Phase 1 Clinical Trial, Scientific Reports (2025)
4. Evaluating the Safety and Feasibility of Prophylactic Third-Party Nk Cell Administration in High-Risk Aml Patients Post-Hsct, BMC Cancer (2025)
5. Ex Vivo-Expanded and Activated Haploidentical Natural Killer Cells Infusion Before Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Phase I/Ii Pilot Study, Cancer Immunology, Immunotherapy (2025)
6. Expression Profiles of Mir-411 and Spry4 As Indicators of Disease Progression and Treatment in Chronic Myelogenous Leukemia, Scientific Reports (2025)
7. Natural Killer Cell Therapy in Hepatocellular Carcinoma: A Comprehensive Review, Discover Oncology (2025)
8. Non-Coding Rnas: Emerging Contributors to Chemoresistance in Chronic Myeloid Leukemia, Leukemia Research Reports (2025)
9. Plasma-Circulating Mir-638, Mir-6511B-5P, Mir-3613-5P, Mir-455-3P, Mir-5787, and Mir-548A-3P As Noninvasive Biomarkers of Immune Reconstitution Post-Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients, Transplant Immunology (2025)
10. Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With Jak2v617f-Negative Polycythemia Vera, Hematology/ Oncology and Stem Cell Therapy (2024)
11. Good Manufacturing Practices Production of Human Placental Derived Mesenchymal Stem Cells for Therapeutic Applications: Focus on Multiple Sclerosis, Molecular Biology Reports (2024)
12. Author Correction: Integrated Genomic Sequencing in Myeloid Blast Crisis Chronic Myeloid Leukemia (Mbc-Cml), Identified Potentially Important Findings in the Context of Leukemogenesis Model (Scientific Reports, (2022), 12, 1, (12816), 10.1038/S41598-022-17232-W), Scientific Reports (2023)
13. Dna Methylation and the Expression of the Tumor-Suppressor Genes Protocadherin-10 and Reprimo in Pediatric Acute Lymphoblastic Leukemia, Iranian Journal of Pediatric Hematology and Oncology (2023)
14. No Association of As3mt Gene Polymorphisms With Susceptibility to Hepatotoxicity and in Apl Patients Treated With As2o3: A Single Center Study, International Journal of Hematology-Oncology and Stem Cell Research (2023)
15. Three Doses of a Recombinant Conjugated Sars-Cov-2 Vaccine Early After Allogeneic Hematopoietic Stem Cell Transplantation: Predicting Indicators of a High Serologic Response—A Prospective, Single-Arm Study, Frontiers in Immunology (2023)
16. A Comparative Study of the Bone Marrow and Umbilical Cord-Derived Mesenchymal Stem Cells (Mscs) Efficiency on Generating Msc-Educated Macrophages (Mems), Asian Pacific Journal of Cancer Prevention (2022)
17. Biological Features of Cd5+ Cd19+ B1 Cell and Natural Igm (Vh4-34) in Chronic Lymphocytic Leukemia Vs. Multiple Sclerosis, Iranian Journal of Allergy# Asthma and Immunology (2022)
18. Do High-Mobility Group Box 1 Gene Polymorphisms Affect the Incidence of Differentiation Syndrome in Acute Promyelocytic Leukemia?, Molecular Biology Reports (2022)
19. Identification of Lncrnas Associated With the Progression of Acute Lymphoblastic Leukemia Using a Competing Endogenous Rnas Network, Oncology Research (2022)
20. Incidence and Prognostic Impact of Wt-1 Gene Exon7 and 9 Mutations in Acute Promyelocytic Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2022)
21. Integrated Genomic Sequencing in Myeloid Blast Crisis Chronic Myeloid Leukemia (Mbc-Cml), Identified Potentially Important Findings in the Context of Leukemogenesis Model, Scientific Reports (2022)
22. Cell Therapy in Patients With Covid-19 Using Wharton’S Jelly Mesenchymal Stem Cells: A Phase 1 Clinical Trial, Stem Cell Research and Therapy (2021)
23. Concurrent Evaluation of the Expression and Methylation of Secreted Frizzled-Related Protein 2 Along With Beta-Catenin Expression in Patients With Non-M3 Acute Myeloid Leukemia, Iranian Journal of Medical Sciences (2021)
24. Promoter Methylation Status and Expression Levels of Rassf1a Gene in Different Phases of Acute Lymphoblastic Leukemia (All), International Journal of Hematology-Oncology and Stem Cell Research (2021)
25. The Impact of Icam-1, Ccl2 and Tgm2 Gene Polymorphisms on Differentiation Syndrome in Acute Promyelocytic Leukemia, BMC Cancer (2021)
26. The Prognostic Impact of Wt1 Expression Levels, Mutations, and Snp Rs16754 in Aml Patients: A Retrospective Cohort Study, Journal of Advances in Medical and Biomedical Research (2021)
27. A Single Center Study of Prescribing and Treatment Outcomes of Patients With Chronic Myeloid Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2020)
28. Curcumin Combined With Thalidomide Reduces Expression of Stat3 and Bcl-Xl, Leading to Apoptosis in Acute Myeloid Leukemia Cell Lines, Drug Design# Development and Therapy (2020)
29. Effects of Sorafenib and Arsenic Trioxide on U937 and Kg-1 Cell Lines: Apoptosis or Autophagy?, Cell Journal (2020)
30. Evaluation of Molecular Response to Imatinib Mesylate Treatment in Iranian Patients With Chronic Myeloid Leukemia, Clinical Lymphoma# Myeloma and Leukemia (2020)
31. The Anticancer Effect of the Tlr4 Inhibition Using Tak-242 (Resatorvid) Either As a Single Agent or in Combination With Chemotherapy: A Novel Therapeutic Potential for Breast Cancer, Journal of Cellular Biochemistry (2020)
32. Arsenic Trioxide and Thalidomide Combination Induces Autophagy Along With Apoptosis in Acute Myeloid Cell Lines, Cell Journal (2019)
33. Comparison of Delta- Pcr and Conventional Fragment Analysis for the Detection of Flt3-Itd Mutations in Paired Diagnosis-Relapse Samples of Patients With Acute Myeloid Leukemia, Journal of Advances in Medical and Biomedical Research (2019)
34. Oral Calcitriol in Hematopoietic Recovery and Survival After Autologous Stem Cell Transplantation: A Randomized Clinical Trial, DARU# Journal of Pharmaceutical Sciences (2019)
35. Study of Stat3 Expression in Different Phases of Patients With Chronic Myeloid Leukemia, Journal of Payavard Salamat (2019)
36. The Correlation Between Egfr and Androgen Receptor Pathways: A Novel Potential Prognostic Marker in Gastric Cancer, Anti-Cancer Agents in Medicinal Chemistry (2019)
37. The Impact of Genetic Variation on Metabolism of Heavy Metals: Genetic Predisposition?, Biomedicine and Pharmacotherapy (2019)
38. Disulfiram/Copper Causes Ros Levels Alteration, Cell Cycle Inhibition, and Apoptosis in Acute Myeloid Leukaemia Cell Lines With Modulation in the Expression of Related Genes, Biomedicine and Pharmacotherapy (2018)
39. Flt3-Itd Compared With Dnmt3a R882 Mutation Is a More Powerful Independent Inferior Prognostic Factor in Adult Acute Myeloid Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study; [Allojenik Hematopoetik Kok Hucre Nakli Sonrasi Yetiskin Akut Myeloid Losemi Hastalarinda, Flt3-Itd, Dnmt3a R882 Mutasyonu Ile Karsilastirildiginda Daha Guclu Bir Bagimsiz Kotu Prognostik Faktordur: Retrospektif Kohort Calismasi], Turkish Journal of Hematology (2018)
40. Inhibitory Effects of Arsenic Trioxide and Thalidomide on Angiogenesis and Vascular Endothelial Growth Factor Expression in Leukemia Cells, Asian Pacific Journal of Cancer Prevention (2018)
41. Investigating the Correlation Between Tgf-Β Gene Expression and Disease-Related Prognostic Factors in Bone Marrow Aspiration of Adults With Acute Lymphoblastic Leukemia, Acta Medica Iranica (2018)
42. Minimal Residual Disease (Mrd) Detection Using Rearrangement of Immunoglobulin/T Cell Receptor Genes in Adult Patients With Acute Lymphoblastic Leukemia (All), Annals of Hematology (2018)
43. Aberrant Methylation of Apaf-1 Gene in Acute Myeloid Leukemia Patients, International Journal of Hematology-Oncology and Stem Cell Research (2017)
44. An Alternative Method for Custom Prime: A Case Report of Successful Peripheral Blood Stem Cell Harvesting From Two Low-Weight Child Donors, Transfusion and Apheresis Science (2017)
45. Dacomitinib, a Pan-Inhibitor of Erbb Receptors, Suppresses Growth and Invasive Capacity of Chemoresistant Ovarian Carcinoma Cells, Scientific Reports (2017)
46. Frequency of M287t/As3mt Single Nucleotide Polymorphism in an Iranian Population, International Journal of Hematology-Oncology and Stem Cell Research (2017)
47. Patterns of Dnmt1 Promoter Methylation in Patients With Acute Lymphoblastic Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2017)
48. Reciprocal Interactions of Leukemic Cells With Bone Marrow Stromal Cells Promote Enrichment of Leukemic Stell Cell Compartments in Response to Curcumin and Daunorubicin, Asian Pacific Journal of Cancer Prevention (2017)
49. The Relationship Between Str-Pcr Chimerism Analysis and Chronic Gvhd Following Hematopoietic Stem Cell Transplantation, International Journal of Hematology-Oncology and Stem Cell Research (2017)
50. Bilateral Maxillary, Sphenoid Sinuses and Lumbosacral Spinal Cord Extramedullary Relapse of Cml Following Allogeneic Stem Cell Transplant, International Journal of Hematology-Oncology and Stem Cell Research (2016)
51. Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia With Npm1 Marker, International Journal of Hematology-Oncology and Stem Cell Research (2016)
52. Effects of Short-Term Pretreatment With Atorvastatin on Mobilization of Hematopoietic Progenitor Cells: A Double-Blind, Randomized, Controlled Trial, International Journal of Hematology-Oncology and Stem Cell Research (2015)
53. Study of Sfrp1 and Sfrp2 Methylation Status in Patients With De Novo Acute Myeloblastic Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2015)
54. Arms-Pcr Versus As-Pcr to Evaluate Jak2v617f Mutation in Patients With Non-Cml Myeloproliferative Neoplasms, Tehran University Medical Journal (2010)
55. Comparisions of Arms-Pcr and As-Pcr for the Evaluation of Jak2v617f Mutation in Patients With Non-Cml Myeloproliferative Neoplasms, International Journal of Hematology-Oncology and Stem Cell Research (2010)
56. Evaluation of Jak2 V617f Mutation and Correlations of This Mutation With Clinical and Laboratory Findings in Patients With Myeloproliferative Neoplasms, Journal of Isfahan Medical School (2010)
57. Jak2-V617f Mutation and Philadelphia Positive Chronic Myeloid Leukemia, International Journal of Hematology-Oncology and Stem Cell Research (2009)